EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences

Wentai Ma, Haoyi Fu iD, Fanchong Jian, Yunlong Cao, Mingkun Li iD

National Science Review · 13.06.2024 · 11 (7)

DOI: 10.1093/nsr/nwae196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift National Science Review, online erschienen am 05.06.2024. Verfasst von Wentai Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Genomics, Chinese Academy of Sciences, and China National Center for Bioinformation, Beijing 100101, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alliance of International Science Organizations, National Natural Science Foundation of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune evasion is a pivotal force shaping the evolution of viruses. Nonetheless, the extent to which virus evolution varies among populations with diverse immune backgrounds remains an unsolved mystery. Prior to the widespread SARS-CoV-2 infections in December 2022 and January 2023, the Chinese population possessed a markedly distinct (less potent) immune background due to its low infection rate, compared to countries experiencing multiple infection waves, presenting an unprecedented opportunity to investigate how the virus has evolved under different immune contexts. We compared the mutation spectrum and functional potential of the newly derived mutations that occurred in BA.5.2.48, BF.7.14 and BA.5.2.49—variants prevalent in China—with their counterparts in other countries. We found that the emerging mutations in the receptor-binding-domain region in these lineages were more widely dispersed and evenly distributed across different epitopes. These mutations led to a higher angiotensin-converting enzyme 2 (ACE2) binding affinity and reduced potential for immune evasion compared to their counterparts in other countries. These findings suggest a milder immune pressure and less evident immune imprinting within the Chinese population. Despite the emergence of numerous immune-evading variants in China, none of them outcompeted the original strain until the arrival of the XBB variant, which had stronger immune evasion and subsequently outcompeted all circulating variants. Our findings demonstrated that the continuously changing immune background led to varying evolutionary pressures on SARS-CoV-2. Thus, in addition to viral genome surveillance, immune background surveillance is also imperative for predicting forthcoming mutations and understanding how these variants spread in the population.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2evolutionmutationpopulation immunity

Autor:innen und Institutionen

  • Beijing Institute of Genomics, Chinese Academy of Sciences, and China National Center for Bioinformation, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing 100871, China.
  • Changping Laboratory, Beijing 102206, China.

ORCID-Profile: Haoyi Fu, Mingkun Li

Förderung

  • Alliance of International Science Organizations
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Ma, W., Fu, H., Jian, F., Cao, Y., & Li, M. (2024). Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences. National Science Review, 11(7). https://doi.org/10.1093/nsr/nwae196

Vancouver

Ma W, Fu H, Jian F, Cao Y, Li M. Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences. National Science Review. 2024;11(7). doi:10.1093/nsr/nwae196

BibTeX
@article{Ma2024,
  author = {Ma, Wentai and Fu, Haoyi and Jian, Fanchong and Cao, Yunlong and Li, Mingkun},
  title = {Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences},
  journal = {National Science Review},
  year = {2024},
  volume = {11},
  number = {7},
  doi = {10.1093/nsr/nwae196}
}
Kostenlos starten →